Shopping Cart 0
Cart Subtotal
USD 0

Optical Coherence Tomography (OCT)-Medical Devices Pipeline Assessment, 2017

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2500

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 5000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 7500

Details

Optical Coherence Tomography (OCT)-Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, "Optical Coherence Tomography (OCT)-Medical Devices Pipeline Assessment, 2017" provides an overview of Optical Coherence Tomography (OCT) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Optical Coherence Tomography (OCT) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Optical Coherence Tomography (OCT) under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Optical Coherence Tomography (OCT) and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons to buy

The report enables you to-

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Optical Coherence Tomography (OCT) under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product's current stage of development, territory and estimated launch date

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Optical Coherence Tomography (OCT) Overview 6

3 Products under Development 7

3.1 Optical Coherence Tomography (OCT)-Pipeline Products by Stage of Development 7

3.2 Optical Coherence Tomography (OCT)-Pipeline Products by Territory 8

3.3 Optical Coherence Tomography (OCT)-Pipeline Products by Regulatory Path 9

3.4 Optical Coherence Tomography (OCT)-Pipeline Products by Estimated Approval Date 10

3.5 Optical Coherence Tomography (OCT)-Ongoing Clinical Trials 11

4 Optical Coherence Tomography (OCT)-Pipeline Products under Development by Companies 12

4.1 Optical Coherence Tomography (OCT) Companies-Pipeline Products by Stage of Development 12

4.2 Optical Coherence Tomography (OCT)-Pipeline Products by Stage of Development 13

5 Optical Coherence Tomography (OCT) Companies and Product Overview 14

5.1 Bioptigen, Inc. Company Overview 14

5.1.1 Bioptigen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 14

5.2 Canon U.S.A. Inc Company Overview 15

5.2.1 Canon U.S.A. Inc Pipeline Products & Ongoing Clinical Trials Overview 15

5.3 Cleveland Clinic Hospital Company Overview 16

5.3.1 Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview 16

5.4 Compact Imaging Inc. Company Overview 17

5.4.1 Compact Imaging Inc. Pipeline Products & Ongoing Clinical Trials Overview 17

5.5 Costruzioni Strumenti Oftalmici Cso Srl Company Overview 18

5.5.1 Costruzioni Strumenti Oftalmici Cso Srl Pipeline Products & Ongoing Clinical Trials Overview 18

5.6 Duke University Company Overview 19

5.6.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 19

5.7 George Washington University Company Overview 23

5.7.1 George Washington University Pipeline Products & Ongoing Clinical Trials Overview 23

5.8 Heidelberg Engineering GmbH Company Overview 24

5.8.1 Heidelberg Engineering GmbH Pipeline Products & Ongoing Clinical Trials Overview 24

5.9 Leica Microsystems GmbH Company Overview 26

5.9.1 Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview 26

5.10 Moorfields Eye Hospital NHS Foundation Trust Company Overview 28

5.10.1 Moorfields Eye Hospital NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview 28

5.11 OptoQuest Company Overview 29

5.11.1 OptoQuest Pipeline Products & Ongoing Clinical Trials Overview 29

5.12 Optos Plc Company Overview 30

5.12.1 Optos Plc Pipeline Products & Ongoing Clinical Trials Overview 30

5.13 Optovue Inc Company Overview 33

5.13.1 Optovue Inc Pipeline Products & Ongoing Clinical Trials Overview 33

5.14 Sinoora Inc. Company Overview 34

5.14.1 Sinoora Inc. Pipeline Products & Ongoing Clinical Trials Overview 34

5.15 University of California Berkeley Company Overview 35

5.15.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 35

5.16 University of Rochester Company Overview 36

5.16.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 36

5.17 Volcano Corp Company Overview 37

5.17.1 Volcano Corp Pipeline Products & Ongoing Clinical Trials Overview 37

6 Optical Coherence Tomography (OCT)- Recent Developments 38

6.1 May 30, 2017: The German Court has Granted a Preliminary Injunction in Favour of VSY Biotechnology BV and Against Carl Zeiss Meditec 38

6.2 May 10, 2017: Carl Zeiss Meditec accelerates growth in the first six months of 2016/17 38

6.3 May 08, 2017: ZEISS Appoints New Fellow 39

6.4 Apr 28, 2017: ZEISS integrates new Barrett Suite into IOLMaster SWEPT Source Biometry for better refractive outcomes and fewer refractive surprises 40

6.5 Apr 25, 2017: Optovue First to Release High Density OCT Angiography for Ophthalmology 41

6.6 Apr 04, 2017: Carl Zeiss Meditec Group achieves first half 2016/17 revenue of approximately EUR 588 million 42

6.7 Mar 19, 2017: Wally Kojima, O.D. and Associates Detects Glaucoma Earlier with FDA-Approved Topcon 3D OCT-1 Maestro 42

6.8 Feb 10, 2017: Carl Zeiss Meditec Off to A Solid Start Into Business Year 2016/17 42

6.9 Jan 31, 2017: Oclaro Announces Second Quarter Fiscal Year 2017 Financial Results 43

6.10 Jan 18, 2017: Oclaro Announces Preliminary Second Quarter Fiscal 2017 Financial Results 45

6.11 Dec 09, 2016: Carl Zeiss Meditec continues its growth trend 45

6.12 Nov 01, 2016: Oclaro Announces First Quarter Fiscal Year 2017 Financial Results 46

6.13 Oct 13, 2016: Carl Zeiss Meditec appoints Steven C. Schallhorn, MD as Chief Medical Officer 47

6.14 Aug 29, 2016: Oclaro Appoints Global Human Resources Veteran to Board of Directors 48

6.15 Aug 12, 2016: Carl Zeiss Meditec Grows in Ophthalmology and Microsurgery 49

6.16 Aug 08, 2016: Optovue Announces New Distribution Agreement With ROCOL in Colombia 50

6.17 Aug 02, 2016: Oclaro Announces Fourth Quarter and Fiscal Year 2016 Financial Results 50

6.18 Jul 27, 2016: Carl Zeiss Meditec Recruits James V. Mazzo to Lead Its Newly Consolidated Ophthalmology Organization 51

6.19 Jul 20, 2016: Carl Zeiss Meditec announces change to Management Board 52

7 Appendix 53

7.1 Methodology 53

7.2 About GlobalData 56

7.3 Contact Us 56

7.4 Disclaimer 56


List Of Figure

1.2 List of Figures

Figure 1: Optical Coherence Tomography (OCT)-Pipeline Products by Stage of Development 7

Figure 2: Optical Coherence Tomography (OCT)-Pipeline Products by Territory 8

Figure 3: Optical Coherence Tomography (OCT)-Pipeline Products by Regulatory Path 9

Figure 4: Optical Coherence Tomography (OCT)-Pipeline Products by Estimated Approval Date 10

Figure 5: Optical Coherence Tomography (OCT)-Ongoing Clinical Trials 11


List Of Table

1.1 List of Tables

Table 1: Optical Coherence Tomography (OCT)-Pipeline Products by Stage of Development 7

Table 2: Optical Coherence Tomography (OCT)-Pipeline Products by Territory 8

Table 3: Optical Coherence Tomography (OCT)-Pipeline Products by Regulatory Path 9

Table 4: Optical Coherence Tomography (OCT)-Pipeline Products by Estimated Approval Date 10

Table 5: Optical Coherence Tomography (OCT)-Ongoing Clinical Trials 11

Table 6: Optical Coherence Tomography (OCT) Companies-Pipeline Products by Stage of Development 12

Table 7: Optical Coherence Tomography (OCT)-Pipeline Products by Stage of Development 13

Table 8: Bioptigen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 14

Table 9: Microscope Integrated Intraoperative OCT-Product Status 14

Table 10: Microscope Integrated Intraoperative OCT-Product Description 14

Table 11: Canon U.S.A. Inc Pipeline Products & Ongoing Clinical Trials Overview 15

Table 12: SPOCT HR-Product Status 15

Table 13: SPOCT HR-Product Description 15

Table 14: Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview 16

Table 15: Interoperative OCT System-Product Status 16

Table 16: Interoperative OCT System-Product Description 16

Table 17: Compact Imaging Inc. Pipeline Products & Ongoing Clinical Trials Overview 17

Table 18: MRO Optical Imaging Sensor-Product Status 17

Table 19: MRO Optical Imaging Sensor-Product Description 17

Table 20: Costruzioni Strumenti Oftalmici Cso Srl Pipeline Products & Ongoing Clinical Trials Overview 18

Table 21: MD-SD-OCT Instrument-Product Status 18

Table 22: MD-SD-OCT Instrument-Product Description 18

Table 23: Duke University Pipeline Products & Ongoing Clinical Trials Overview 19

Table 24: HH-SDOCT-Product Status 19

Table 25: HH-SDOCT-Product Description 19

Table 26: Microscope Integrated OCT System-Product Status 20

Table 27: Microscope Integrated OCT System-Product Description 20

Table 28: Duke University-Ongoing Clinical Trials Overview 21

Table 29: Microscope Integrated OCT System-Intraoperative OCT Guidance of Intraocular Surgery 22

Table 30: George Washington University Pipeline Products & Ongoing Clinical Trials Overview 23

Table 31: Amplified Bimorph Scanning Mirror System-Product Status 23

Table 32: Amplified Bimorph Scanning Mirror System-Product Description 23

Table 33: Heidelberg Engineering GmbH Pipeline Products & Ongoing Clinical Trials Overview 24

Table 34: Cataract And Refractive Imaging Platform-Product Status 24

Table 35: Cataract And Refractive Imaging Platform-Product Description 24

Table 36: SPECTRALIS OCT2 Module-OCT Angiography-Product Status 25

Table 37: SPECTRALIS OCT2 Module-OCT Angiography-Product Description 25

Table 38: Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview 26

Table 39: DI-SDOCT Imaging System-Product Status 26

Table 40: DI-SDOCT Imaging System-Product Description 26

Table 41: SDOCT Scanner-Product Status 27

Table 42: SDOCT Scanner-Product Description 27

Table 43: Moorfields Eye Hospital NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview 28

Table 44: Binocular Optical Coherence Tomography-Product Status 28

Table 45: Binocular Optical Coherence Tomography-Product Description 28

Table 46: OptoQuest Pipeline Products & Ongoing Clinical Trials Overview 29

Table 47: Vectralis-Product Status 29

Table 48: Vectralis-Product Description 29

Table 49: Optos Plc Pipeline Products & Ongoing Clinical Trials Overview 30

Table 50: Falcon I-Product Status 30

Table 51: Falcon I-Product Description 30

Table 52: Falcon II-Product Status 31

Table 53: Falcon II-Product Description 31

Table 54: Lotte-Product Status 31

Table 55: Lotte-Product Description 32

Table 56: Optovue Inc Pipeline Products & Ongoing Clinical Trials Overview 33

Table 57: AngioAnalytics-Product Status 33

Table 58: AngioAnalytics-Product Description 33

Table 59: Sinoora Inc. Pipeline Products & Ongoing Clinical Trials Overview 34

Table 60: On-chip Spectral Coherence Tomography System-Product Status 34

Table 61: On-chip Spectral Coherence Tomography System-Product Description 34

Table 62: University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 35

Table 63: Directional Optical Coherence Tomography Device-Product Status 35

Table 64: Directional Optical Coherence Tomography Device-Product Description 35

Table 65: University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 36

Table 66: Scanning Optical System-Product Status 36

Table 67: Scanning Optical System-Product Description 36

Table 68: Volcano Corp Pipeline Products & Ongoing Clinical Trials Overview 37

Table 69: Swept Laser Integrated OEM OCT Ophthalmic OCT System-Product Status 37

Table 70: Swept Laser Integrated OEM OCT Ophthalmic OCT System-Product Description 37

Table 71: Glossary 55

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Bioptigen, Inc., Canon U.S.A. Inc, Cleveland Clinic Hospital, Compact Imaging Inc., Costruzioni Strumenti Oftalmici Cso Srl, Duke University, George Washington University, Heidelberg Engineering GmbH, Leica Microsystems GmbH, Moorfields Eye Hospital NHS Foundation Trust, OptoQuest, Optos Plc, Optovue Inc, Sinoora Inc., University of California Berkeley, University of Rochester, Volcano Corp

Company Profile

Company Profile Title

Optical Coherence Tomography (OCT)-Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, "Optical Coherence Tomography (OCT)-Medical Devices Pipeline Assessment, 2017" provides an overview of Optical Coherence Tomography (OCT) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Optical Coherence Tomography (OCT) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Optical Coherence Tomography (OCT) under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Optical Coherence Tomography (OCT) and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons to buy

The report enables you to-

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Optical Coherence Tomography (OCT) under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product's current stage of development, territory and estimated launch date

READ MORE

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Optical Coherence Tomography (OCT) Overview 6

3 Products under Development 7

3.1 Optical Coherence Tomography (OCT)-Pipeline Products by Stage of Development 7

3.2 Optical Coherence Tomography (OCT)-Pipeline Products by Territory 8

3.3 Optical Coherence Tomography (OCT)-Pipeline Products by Regulatory Path 9

3.4 Optical Coherence Tomography (OCT)-Pipeline Products by Estimated Approval Date 10

3.5 Optical Coherence Tomography (OCT)-Ongoing Clinical Trials 11

4 Optical Coherence Tomography (OCT)-Pipeline Products under Development by Companies 12

4.1 Optical Coherence Tomography (OCT) Companies-Pipeline Products by Stage of Development 12

4.2 Optical Coherence Tomography (OCT)-Pipeline Products by Stage of Development 13

5 Optical Coherence Tomography (OCT) Companies and Product Overview 14

5.1 Bioptigen, Inc. Company Overview 14

5.1.1 Bioptigen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 14

5.2 Canon U.S.A. Inc Company Overview 15

5.2.1 Canon U.S.A. Inc Pipeline Products & Ongoing Clinical Trials Overview 15

5.3 Cleveland Clinic Hospital Company Overview 16

5.3.1 Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview 16

5.4 Compact Imaging Inc. Company Overview 17

5.4.1 Compact Imaging Inc. Pipeline Products & Ongoing Clinical Trials Overview 17

5.5 Costruzioni Strumenti Oftalmici Cso Srl Company Overview 18

5.5.1 Costruzioni Strumenti Oftalmici Cso Srl Pipeline Products & Ongoing Clinical Trials Overview 18

5.6 Duke University Company Overview 19

5.6.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 19

5.7 George Washington University Company Overview 23

5.7.1 George Washington University Pipeline Products & Ongoing Clinical Trials Overview 23

5.8 Heidelberg Engineering GmbH Company Overview 24

5.8.1 Heidelberg Engineering GmbH Pipeline Products & Ongoing Clinical Trials Overview 24

5.9 Leica Microsystems GmbH Company Overview 26

5.9.1 Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview 26

5.10 Moorfields Eye Hospital NHS Foundation Trust Company Overview 28

5.10.1 Moorfields Eye Hospital NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview 28

5.11 OptoQuest Company Overview 29

5.11.1 OptoQuest Pipeline Products & Ongoing Clinical Trials Overview 29

5.12 Optos Plc Company Overview 30

5.12.1 Optos Plc Pipeline Products & Ongoing Clinical Trials Overview 30

5.13 Optovue Inc Company Overview 33

5.13.1 Optovue Inc Pipeline Products & Ongoing Clinical Trials Overview 33

5.14 Sinoora Inc. Company Overview 34

5.14.1 Sinoora Inc. Pipeline Products & Ongoing Clinical Trials Overview 34

5.15 University of California Berkeley Company Overview 35

5.15.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 35

5.16 University of Rochester Company Overview 36

5.16.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 36

5.17 Volcano Corp Company Overview 37

5.17.1 Volcano Corp Pipeline Products & Ongoing Clinical Trials Overview 37

6 Optical Coherence Tomography (OCT)- Recent Developments 38

6.1 May 30, 2017: The German Court has Granted a Preliminary Injunction in Favour of VSY Biotechnology BV and Against Carl Zeiss Meditec 38

6.2 May 10, 2017: Carl Zeiss Meditec accelerates growth in the first six months of 2016/17 38

6.3 May 08, 2017: ZEISS Appoints New Fellow 39

6.4 Apr 28, 2017: ZEISS integrates new Barrett Suite into IOLMaster SWEPT Source Biometry for better refractive outcomes and fewer refractive surprises 40

6.5 Apr 25, 2017: Optovue First to Release High Density OCT Angiography for Ophthalmology 41

6.6 Apr 04, 2017: Carl Zeiss Meditec Group achieves first half 2016/17 revenue of approximately EUR 588 million 42

6.7 Mar 19, 2017: Wally Kojima, O.D. and Associates Detects Glaucoma Earlier with FDA-Approved Topcon 3D OCT-1 Maestro 42

6.8 Feb 10, 2017: Carl Zeiss Meditec Off to A Solid Start Into Business Year 2016/17 42

6.9 Jan 31, 2017: Oclaro Announces Second Quarter Fiscal Year 2017 Financial Results 43

6.10 Jan 18, 2017: Oclaro Announces Preliminary Second Quarter Fiscal 2017 Financial Results 45

6.11 Dec 09, 2016: Carl Zeiss Meditec continues its growth trend 45

6.12 Nov 01, 2016: Oclaro Announces First Quarter Fiscal Year 2017 Financial Results 46

6.13 Oct 13, 2016: Carl Zeiss Meditec appoints Steven C. Schallhorn, MD as Chief Medical Officer 47

6.14 Aug 29, 2016: Oclaro Appoints Global Human Resources Veteran to Board of Directors 48

6.15 Aug 12, 2016: Carl Zeiss Meditec Grows in Ophthalmology and Microsurgery 49

6.16 Aug 08, 2016: Optovue Announces New Distribution Agreement With ROCOL in Colombia 50

6.17 Aug 02, 2016: Oclaro Announces Fourth Quarter and Fiscal Year 2016 Financial Results 50

6.18 Jul 27, 2016: Carl Zeiss Meditec Recruits James V. Mazzo to Lead Its Newly Consolidated Ophthalmology Organization 51

6.19 Jul 20, 2016: Carl Zeiss Meditec announces change to Management Board 52

7 Appendix 53

7.1 Methodology 53

7.2 About GlobalData 56

7.3 Contact Us 56

7.4 Disclaimer 56


List Of Figure

1.2 List of Figures

Figure 1: Optical Coherence Tomography (OCT)-Pipeline Products by Stage of Development 7

Figure 2: Optical Coherence Tomography (OCT)-Pipeline Products by Territory 8

Figure 3: Optical Coherence Tomography (OCT)-Pipeline Products by Regulatory Path 9

Figure 4: Optical Coherence Tomography (OCT)-Pipeline Products by Estimated Approval Date 10

Figure 5: Optical Coherence Tomography (OCT)-Ongoing Clinical Trials 11


List Of Table

1.1 List of Tables

Table 1: Optical Coherence Tomography (OCT)-Pipeline Products by Stage of Development 7

Table 2: Optical Coherence Tomography (OCT)-Pipeline Products by Territory 8

Table 3: Optical Coherence Tomography (OCT)-Pipeline Products by Regulatory Path 9

Table 4: Optical Coherence Tomography (OCT)-Pipeline Products by Estimated Approval Date 10

Table 5: Optical Coherence Tomography (OCT)-Ongoing Clinical Trials 11

Table 6: Optical Coherence Tomography (OCT) Companies-Pipeline Products by Stage of Development 12

Table 7: Optical Coherence Tomography (OCT)-Pipeline Products by Stage of Development 13

Table 8: Bioptigen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 14

Table 9: Microscope Integrated Intraoperative OCT-Product Status 14

Table 10: Microscope Integrated Intraoperative OCT-Product Description 14

Table 11: Canon U.S.A. Inc Pipeline Products & Ongoing Clinical Trials Overview 15

Table 12: SPOCT HR-Product Status 15

Table 13: SPOCT HR-Product Description 15

Table 14: Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview 16

Table 15: Interoperative OCT System-Product Status 16

Table 16: Interoperative OCT System-Product Description 16

Table 17: Compact Imaging Inc. Pipeline Products & Ongoing Clinical Trials Overview 17

Table 18: MRO Optical Imaging Sensor-Product Status 17

Table 19: MRO Optical Imaging Sensor-Product Description 17

Table 20: Costruzioni Strumenti Oftalmici Cso Srl Pipeline Products & Ongoing Clinical Trials Overview 18

Table 21: MD-SD-OCT Instrument-Product Status 18

Table 22: MD-SD-OCT Instrument-Product Description 18

Table 23: Duke University Pipeline Products & Ongoing Clinical Trials Overview 19

Table 24: HH-SDOCT-Product Status 19

Table 25: HH-SDOCT-Product Description 19

Table 26: Microscope Integrated OCT System-Product Status 20

Table 27: Microscope Integrated OCT System-Product Description 20

Table 28: Duke University-Ongoing Clinical Trials Overview 21

Table 29: Microscope Integrated OCT System-Intraoperative OCT Guidance of Intraocular Surgery 22

Table 30: George Washington University Pipeline Products & Ongoing Clinical Trials Overview 23

Table 31: Amplified Bimorph Scanning Mirror System-Product Status 23

Table 32: Amplified Bimorph Scanning Mirror System-Product Description 23

Table 33: Heidelberg Engineering GmbH Pipeline Products & Ongoing Clinical Trials Overview 24

Table 34: Cataract And Refractive Imaging Platform-Product Status 24

Table 35: Cataract And Refractive Imaging Platform-Product Description 24

Table 36: SPECTRALIS OCT2 Module-OCT Angiography-Product Status 25

Table 37: SPECTRALIS OCT2 Module-OCT Angiography-Product Description 25

Table 38: Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview 26

Table 39: DI-SDOCT Imaging System-Product Status 26

Table 40: DI-SDOCT Imaging System-Product Description 26

Table 41: SDOCT Scanner-Product Status 27

Table 42: SDOCT Scanner-Product Description 27

Table 43: Moorfields Eye Hospital NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview 28

Table 44: Binocular Optical Coherence Tomography-Product Status 28

Table 45: Binocular Optical Coherence Tomography-Product Description 28

Table 46: OptoQuest Pipeline Products & Ongoing Clinical Trials Overview 29

Table 47: Vectralis-Product Status 29

Table 48: Vectralis-Product Description 29

Table 49: Optos Plc Pipeline Products & Ongoing Clinical Trials Overview 30

Table 50: Falcon I-Product Status 30

Table 51: Falcon I-Product Description 30

Table 52: Falcon II-Product Status 31

Table 53: Falcon II-Product Description 31

Table 54: Lotte-Product Status 31

Table 55: Lotte-Product Description 32

Table 56: Optovue Inc Pipeline Products & Ongoing Clinical Trials Overview 33

Table 57: AngioAnalytics-Product Status 33

Table 58: AngioAnalytics-Product Description 33

Table 59: Sinoora Inc. Pipeline Products & Ongoing Clinical Trials Overview 34

Table 60: On-chip Spectral Coherence Tomography System-Product Status 34

Table 61: On-chip Spectral Coherence Tomography System-Product Description 34

Table 62: University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 35

Table 63: Directional Optical Coherence Tomography Device-Product Status 35

Table 64: Directional Optical Coherence Tomography Device-Product Description 35

Table 65: University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 36

Table 66: Scanning Optical System-Product Status 36

Table 67: Scanning Optical System-Product Description 36

Table 68: Volcano Corp Pipeline Products & Ongoing Clinical Trials Overview 37

Table 69: Swept Laser Integrated OEM OCT Ophthalmic OCT System-Product Status 37

Table 70: Swept Laser Integrated OEM OCT Ophthalmic OCT System-Product Description 37

Table 71: Glossary 55

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Bioptigen, Inc., Canon U.S.A. Inc, Cleveland Clinic Hospital, Compact Imaging Inc., Costruzioni Strumenti Oftalmici Cso Srl, Duke University, George Washington University, Heidelberg Engineering GmbH, Leica Microsystems GmbH, Moorfields Eye Hospital NHS Foundation Trust, OptoQuest, Optos Plc, Optovue Inc, Sinoora Inc., University of California Berkeley, University of Rochester, Volcano Corp